Statistics for Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer
Total visits
| views | |
|---|---|
| Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer | 20 |
Total visits per month
| views | |
|---|---|
| January 2025 | 0 |
| February 2025 | 1 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| Oncogene.pdf(legacy) | 30 |
| Oncogene.pdf | 5 |
| Dina_Coelho.pdf(legacy) | 1 |
Top country views
| views | |
|---|---|
| Portugal | 11 |
| United States | 4 |
| China | 3 |
| Russia | 1 |
| Turkey | 1 |